31 Publications (Page 1 of 2)
2013
Epigenetic targeting therapies to overcome chemotherapy resistance.
Balch, Curtis and Nephew, Ken
Advances in experimental medicine and biology, vol. 754, pp. 285-311, 2013. | Journal Article
2012
A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells.
Balch, CurtisNaegeli, KalebNam, SeungyoonBallard, BrettHyslop, AlanMelki, ChristinaReilly, ElizabethHur, Man-Wook and Nephew, Ken
Cancer biology & therapy, vol. 13, (no. 8), pp. 681-93, 2012/Jun. | Journal Article
 
Growth inhibition of ovarian tumor-initiating cells by niclosamide.
Yo, Yi-TeLin, Ya-WenWang, Yu-ChiBalch, CurtisHuang, Rui-LanChan, Michael WSytwu, Huey-KangChen, Chi-KuanChang, Cheng-ChangNephew, KenHuang, TimYu, Mu-Hsien and Lai, Hung-Cheng
Molecular cancer therapeutics, vol. 11, (no. 8), pp. 1703-12, 2012/Aug. | Journal Article
 
Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug Development
Hahn, Noah MHahn, NoahBonney, Patty LBonney, PattyDhawan, DeepikaDhawan, DeepikaJones, David RJones, DavidBalch, CurtisBalch, CurtisGuo, ZhongminGuo, ZhongminHartman-Frey, CorieHartman-Frey, CorieFang, FangFang, FangParker, Heidi GParker, HeidiKwon, Erika MKwon, ErikaOstrander, Elaine AOstrander, ElaineNephew, KenNephew, KennethKnapp, Deborah and Knapp, Deborah W
Journal of Urology, vol. 187, (no. 1), pp. 302-309, 2012. | Journal Article
 
The influence of cis-regulatory elements on DNA methylation fidelity.
Teng, MingxiangTeng, MingxiangBalch, CurtisBalch, CurtLiu, YunlongLiu, YunlongLi, MengLi, MengHuang, Tim HHuang, Tim H MWang, YadongWang, YadongNephew, KenNephew, Kenneth PLi, Lang and Li, Lang
PloS one, vol. 7, (no. 3), pp. e32928, 2012. | Journal Article
2010
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.
Fang, FangFang, FangBalch, CurtisBalch, CurtSchilder, JeanneSchilder, Jeanne MBreen, TimothyBreen, TimothyZhang, ShuZhang, ShuShen, ChangyuShen, ChangyuLi, LangLi, LangKulesavage, CarolKulesavage, CarolSnyder, Anthony JSnyder, Anthony JNephew, Kenneth PNephew, KenMatei, Daniela E and Matei, Daniela E
Cancer, vol. 116, (no. 17), pp. 4043-53, 2010/Sep/1. | Journal Article
 
Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications
Kwon, Mi JKim, Sung-SuChoi, Yoon-LaJung, Hun SBalch, CurtisKim, Su-HyeongSong, Yong-SangMarquez, Victor ENephew, Kenneth P and Shin, Young K
Carcinogenesis, vol. 31, (no. 6), pp. 974-983, 2010. | Journal Article
 
Epigenetics and Ovarian Cancer
Nephew, KenBalch, CurtisZhang, S. and Huang, TH-M
Cancer Treatment and Research, vol. 149, pp. 131-146, 2010. | Journal Article
 
Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
Bapat, Sharmila AJin, VictorBerry, NicholasBalch, CurtisSharma, NeetiKurrey, NawneetZhang, ShuFang, FangLan, XunLi, MengKennedy, BrianBigsby, Robert MHuang, Tim H and Nephew, Ken
Epigenetics : official journal of the DNA Methylation Society, vol. 5, (no. 8), pp. 716-29, 2010 Nov-Dec. | Journal Article
 
Role of epigenomics in ovarian and endometrial cancers.
Balch, CurtisMatei, Daniela EHuang, Tim H and Nephew, Ken
Epigenomics, vol. 2, (no. 3), pp. 419-47, 2010/Jun. | Journal Article
 
The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.
Balch, Curtis and Nephew, Ken
Cancer biomarkers : section A of Disease markers, vol. 8, (no. 4-5), pp. 203-21, 2010-2011. | Journal Article
2009
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules.
Qin, HuaxiaChan, Michael WLiyanarachchi, SandyaBalch, CurtisPotter, DustinSouriraj, Irene JCheng, Alfred SAgosto-Perez, Francisco JNikonova, Elena VYan, Pearlly SLin, Huey JenNephew, KenSaltz, Joel HShowe, Louise CHuang, Tim H and Davuluri, Ramana V
BMC systems biology, vol. 3, pp. 73, 2009. | Journal Article
 
A rationally designed histone deacetylase inhibitor with distinct antitumor activity against ovarian cancer.
Yang, Ya-TingBalch, CurtisKulp, Samuel KMand, Michael RNephew, Ken and Chen, Ching Shih
Neoplasia (New York, N.Y.), vol. 11, (no. 6), pp. 552-63, 3 p following 563, 2009/Jun. | Journal Article
 
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
Xin, FuxiaoLi, MengBalch, CurtisThomson, MichaelFan, MeiyunLiu, YunlongHammond, Scott MKim, Sun and Nephew, Ken
Bioinformatics, vol. 25, (no. 4), pp. 430-434, 2009. | Journal Article
 
Epigenetics and ovarian cancer.
Nephew, KenBalch, CurtisZhang, Shu and Huang, Tim H
Cancer treatment and research, vol. 149, pp. 131-46, 2009. | Journal Article
 
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer.
Li, MengBalch, CurtisMontgomery, John SJeong, MikyoungChung, Jae HYan, Pearlly SHuang, Tim HKim, Sun and Nephew, Ken
BMC medical genomics, vol. 2, pp. 34, 2009. | Journal Article
 
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression
Nam, SeungyoonLi, MengChoi, KwangminBalch, CurtisKim, Sun and Nephew, Ken
Nucleic Acids Research, vol. 37, (no. suppl_2), pp. W356-W362, 2009. | Journal Article
 
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression.
Nam, SeungyoonLi, MengChoi, KwangminBalch, CurtisKim, Sun and Nephew, Ken
Nucleic acids research., vol. 37, pp. W356-W362, 2009. | Journal Article
 
MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression.
Nam, SeungyoonLi, MengChoi, KwangminBalch, CurtisKim, Sun and Nephew, Ken
Nucleic acids research, vol. 37, (no. Web Server issue), pp. W356-62, 2009/Jul. | Journal Article
 
Minireview: epigenetic changes in ovarian cancer.
Balch, CurtisBalch, CurtFang, FangFang, FangMatei, Daniela EMatei, Daniela EHuang, Tim H-MHuang, Tim HNephew, Kenneth P and Nephew, Ken
Endocrinology, vol. 150, (no. 9), pp. 4003-11, 2009/Sep. | Journal Article
2008
Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells
Li, MengPaik, Hyun-il HBalch, CurtisKim, YoosungLi, LangHuang, Tim HNephew, Ken and Kim, Sun
Bioinformatics, vol. 24, (no. 16), pp. 1745-8, Aug 15, 2008. | Journal Article
 
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, ShuZhang, ShuBalch, CurtBalch, CurtisChan, MichaelChan, Michael WLai, Hung-ChengLai, Hung-ChengMatei, Daniela EMatei, DanielaSchilder, JeanneSchilder, Jeanne MYan, PearllyYan, Pearlly SHuang, Tim HHuang, TimNephew, Kenneth and Nephew, Ken
Cancer Research, vol. 68, (no. 11), pp. 4311-4320, 2008. | Journal Article
2007
Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis
Balch, CurtisNephew, KenHuang, Tim H and Bapat, Sharmila A
BioEssays., vol. 29, (no. 9), pp. 842-845, 2007. | Journal Article
2006
A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-[alpha]
Li, LangCheng, Alfred SJin, VictorPaik, Henry HFan, MeiyunLi, XiaomanZhang, WeiRobarge, JasonBalch, CurtisDavuluri, Ramana VKim, SunHuang, Tim H and Nephew, Ken
Bioinformatics, vol. 22, (no. 18), pp. 2210, Sep 15, 2006. | Journal Article
 
Dominant-Negative Histone H3 Lysine 27 Mutant Derepresses Silenced Tumor Suppressor Genes and Reverses the Drug-Resistant Phenotype in Cancer Cells
Abbosh, Phillip HMontgomery, John SStarkey, Jason ANovotny, MilosZuhowski, Eleanor GEgorin, Merrill JMoseman, Annie PGolas, AdamBrannon, Kate MBalch, CurtisHuang, Tim H and Nephew, Ken
Cancer Research, vol. 66, (no. 11), pp. 5582-5591, 2006. | Journal Article